Purple Pharmaceuticals

Purlevo-500

For tough & stubborn Bacteria provide the promising dosing

Purlevo-500

Lenvofloxacin 500 mg tablets

• Offers 100% Coverage with 90% Bioavailabilty

• Lowers the risk of resistance & assured patient compliance as com[are to ofloxacin as well as Ciprofloxacin

• Active against gram +ve cocci including pencillin resistance pneumococci & anaerobes.

• MIC is double against S.Pneumoniae [Int.j.of Antimicrobial Agent (1999) 43]

Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.

close-up, drugs, medical

In The Management of:

Community Acquired Pneumonia

Complicated U.T.I

Skin & Soft Tissue Infections

Acute A.E.C.B

Acute Maxillary Sinusitis

Purlevo-500........Provide the Promising Result